Meta-analysis of randomized controlled trials investigating the risk of postoperative infection in association with white blood cell-containing allogeneic blood transfusion: The effects of the type of transfused red blood cell product and surgical setting

Transfusion Medicine Reviews

Volumn 16, Issue 4, 2002, Pages 304-314

  Vamvakas, Eleftherios C ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL SURGERY; ARTICLE; BACTERIAL INFECTION; BLOOD AUTOTRANSFUSION; BLOOD STORAGE; BLOOD TRANSFUSION; CLINICAL TRIAL; ERYTHROCYTE TRANSFUSION; HUMAN; IMMUNOMODULATION; INFECTION RISK; META ANALYSIS; OPEN HEART SURGERY; POSTOPERATIVE INFECTION; RANDOMIZATION; STATISTICAL ANALYSIS; CELL SEPARATION; CONTROLLED CLINICAL TRIAL; FILTRATION; INFECTION; INFECTION CONTROL; LEUKOCYTE COUNT; MEDLINE; METHODOLOGY; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STANDARD; STATISTICS;

BLOOD TRANSFUSION; CELL SEPARATION; ERYTHROCYTE TRANSFUSION; FILTRATION; HUMANS; INFECTION; INFECTION CONTROL; LEUKOCYTE COUNT; MEDLINE; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS;

EID: 0036806218     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1053/tmrv.2002.35209     Document Type: Article

References (36)

1. Vamvakas EC, Blajchman MA: Deleterious clinical effects of transfusion-associated immunomodulation: Fact or fiction? Blood 97:1180-1195, 2001
2. Bordin JO, Heddle NM, Blajchman MA: Biologic effects of leukocytes present in transfused cellular blood products. Blood 84:1705-1721, 1994
3. Nielsen HJ, Reimert CM, Pedersen AN, et al: Time-dependent, spontaneous release of white cell- and platelet-derived bioactive substances from stored human blood. Transfusion 36:960-965, 1996
4. Ghio M, Contini P, Mazzei C, et al: Soluble HLA Class I, HLA Class II, and Fas ligand in blood components: A possible key to explain the immunomodulatory effects of allogeneic blood transfusion. Blood 93:1770-1777, 1999
5. Magee CC, Sayegh MH: Peptide-mediated immunosuppression. Curr Opin Immunol 9:669-675, 1997
6. Heiss MM, Mempel W, Jausch K-W, et al: Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet 342:1328-1333, 1993
7. Busch ORC, Hop WCJ, van Papendrecht MAWH, et al: Blood transfusions and prognosis in colorectal cancer. N Engl J Med 328:1372-1376, 1993
8. Nielsen HJ: Detrimental effects of perioperative blood transfusion. Br J Surg 82:582-587, 1995
9. Jensen LS, Andersen AJ, Christiansen PM, et al: Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 79:513-516, 1992
10. Houbiers JGA, Brand A, van de Watering LMG, et al: Randomized controlled trial comparing transfusion of leukocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 344:573-578, 1994
11. Jensen LS, Kissmeyer-Nielsen P, Wolff B, et al: Randomized comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 34:841-845, 1996
12. van de Watering LMG, Hermans J, Houbiers JGA, et al: Beneficial effect of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: A randomized clinical trial. Circulation 97:562-568, 1998
13. Tartter PI, Mohandas K, Azar P, et al: Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. Am J Surg 176:462-466, 1998
14. Vamvakas EC: Possible mechanisms of allogeneic blood transfusion-associated postoperative infection. Transfus Med Rev 16:144-160, 2002
15. Vamvakas EC: Transfusion-associated cancer recurrence and infection: Meta-analysis of the randomized controlled clinical trials. Transfusion 36:175-186, 1996
16. McAlister FA, Clark HD, Wells PS, et al: Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: A meta-analysis of unconfounded studies. Br J Surg 85:171-178, 1998
17. Wallis JP, Champman CE, Orr KE, et al: Effects of white cell depletion of red cells on postoperative infection rates in cardiac surgery. Transfus Med 9:43S, 1999 (suppl, abstr)
18. Titlestad IL, Ebbesen LS, Ainsworth AP, et al: Leukocyte-depletion of blood components does not significantly reduce the risk of infectious complications: Results of a double-blind, randomized study. Int J Colorectal Dis 16:147-153, 2001
19. Bilgin YM, van de Watering LMG, Lorinser JE, et al: The effects of prestorage leukocyte-depletion of erythrocyte concentrates in cardiac surgery: A double-blind randomized clinical trial. Blood 98:828a-829a, 2001 (suppl, abstr)
20. Collier A, Kalish L, Busch M, et al: Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection. JAMA 285:1592-1601, 2001
21. Heiss MN, Mempel W, Delanoff C, et al: Blood transfusion-modulated tumor recurrence: First results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 12:1859-1867, 1994
22. Dzik S, Anderson JK, O'Neill M, et al: A prospective randomized clinical trial of universal leukoreduction. Transfusion 41:1S, 2001 (suppl, abstr)
23. Newman JH, Bowers M, Murphy J: The clinical advantages of autologous transfusion: A randomized, controlled study after knee replacement. J Bone Joint Surg Br 79:630-632, 1997
24. Thomas D, Wareham K, Cohen D, et al: Autologous blood transfusion in total knee replacement surgery. Br J Anaesth 86:669-673, 2001
25. Farrer A, Spark JI, Scott DJ: Autologous blood transfusion: The benefits for the patient undergoing abdominal aortic aneurysm repair. J Vasc Nurs 15:111-115, 1997
26. Murphy S, Nixon J, Hunter S: Leukocyte content of fresh frozen plasma exceeds standards for leukoreduced blood components. Transfusion 39:16S, 1999 (suppl, abstr)
27. Gresens CJ, Paglieroni TG, Moss CB, et al: WBC populations in thawed fresh frozen plasma. Transfusion 39:99S, 1999 (suppl, abstr)
28. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 7:177-188, 1986
29. Cooper H, Hedges LV, eds: The Handbook of Research Synthesis. New York, NY, Russell Sage Foundation, 1994
30. Heddle NM, Klama L, Griffith L, et al: A prospective study to identify risk factors associated with acute reactions to platelet and red cell transfusion. Transfusion 33:794-7, 1993
31. Heddle NM, Meyer R, Sher G. et al: A randomized control trial comparing plasma removal to two types of prestorage leukoreduction to prevent reactions to platelets. Transfusion 39:96S, 1999 (suppl, abstr)
32. Vamvakas EC, Blajchman MA: Universal white-cell reduction: The case for and against. Transfusion 41:691-712, 2001
33. Bordin JO, Bardossy L, Blajchman MA: Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: The importance of timing of the leukodepletion. Blood 84:344-348, 1994
34. Vamvakas EC, Blajchman MA: Prestorage versus poststorage white cell reduction for the prevention of the deleterious immunomodulatory effects of allogeneic blood transfusion. Transfus Med Rev 14:23-33, 2000
35. Kao KJ: Induction of humoral immune tolerance to major histocompatibility complex antigens by transfusions of UV-B irradiated leukocytes. Blood 88:4375-4382, 1996
36. Vamvakas EC: Multicenter randomized controlled trials in transfusion medicine. Transfus Med Rev 14:137-150, 2000